Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Atea Pharmaceuticals, Inc. | EVP, Chief Accounting Officer | Restricted Stock Units | 66.7K | $256K | $3.84 | Jan 31, 2024 | Direct |
Atea Pharmaceuticals, Inc. | EVP, Chief Accounting Officer | Common Stock | 20.9K | $80.1K | $3.84 | Feb 1, 2024 | Direct |
Atea Pharmaceuticals, Inc. | EVP, Chief Accounting Officer | Stock Option (Right to Buy) | 120K | Jan 31, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AVIR | Atea Pharmaceuticals, Inc. | Jan 31, 2024 | 4 | -$47.9K | 4 | Feb 2, 2024 | EVP, Chief Accounting Officer |
AVIR | Atea Pharmaceuticals, Inc. | Jan 31, 2023 | 2 | $0 | 4 | Feb 2, 2023 | EVP, Chief Accounting Officer |
AVIR | Atea Pharmaceuticals, Inc. | Jan 31, 2022 | 1 | $0 | 4 | Feb 2, 2022 | EVP, Chief Accounting Officer |